Next Article in Journal
Energy Expenditure and Changes in Body Composition During Submarine Deployment—An Observational Study “DasBoost 2-2017”
Next Article in Special Issue
Phenolic Composition, Mineral Content, and Beneficial Bioactivities of Leaf Extracts from Black Currant (Ribes nigrum L.), Raspberry (Rubus idaeus), and Aronia (Aronia melanocarpa)
Previous Article in Journal
The Effect of Timing of Exercise and Eating on Postprandial Response in Adults: A Systematic Review
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Chemical Profile, Antioxidative, and Gut Microbiota Modulatory Properties of Ganpu Tea: A Derivative of Pu-erh Tea

Guangdong Engineering & Technology Research Center for Quality and Efficacy Reevaluation of Post-Market Traditional Chinese Medicine, Guangdong Provincial Key Laboratory of Plant Resources, School of Life Sciences, Sun Yat-sen University, Guangzhou 510275, China
*
Author to whom correspondence should be addressed.
Nutrients 2020, 12(1), 224; https://doi.org/10.3390/nu12010224
Submission received: 31 December 2019 / Revised: 8 January 2020 / Accepted: 11 January 2020 / Published: 15 January 2020
(This article belongs to the Special Issue Plant Bioactive Compounds for Health Benefits and Nutrition)

Abstract

:
Ganpu tea is an emerging tea drink produced from Pu-erh tea and the pericarp of Citrus reticulate Chachi (GCP). Recently, it has been increasingly favored by consumers due to the potential health effects and special taste. However, information concerning its chemical profile and biological activities is scarce. In this work, a total of 92 constituents were identified in hot-water extracts of Ganpu tea with ultra-high performance liquid chromatography/quadrupole-time-of-flight tandem mass spectrometry (UHPLC-Q-TOF-MS/MS). Moreover, the antioxidative and gut microbiota modulatory properties of Ganpu tea were investigated in rats after long-term dietary consumption. Ganpu tea and GCP could significantly enhance the activities of superoxide dismutase (SOD) by 13.4% (p < 0.05) and 15.1% (p < 0.01), as well as the activities of glutathione peroxidase (GSH-Px) by 16.3% (p < 0.01) and 20.5% (p < 0.01), respectively. Both showed better antioxidant capacities than Pu-erh tea. Ganpu tea increased the abundance of Bifidobacterium, Lactobacillus, and Lactococcus, suggesting the potential of Ganpu tea in modulating the gut microbiota to benefit human health. The obtained results provide essential information for further investigation of Ganpu tea.

Graphical Abstract

1. Introduction

Pu-erh tea is a microbial fermented tea produced using sun-dried leaves of large-leaf tea species (Camellia sinensis (Linn.) var. assamica (Masters) Kitamura) in Yunnan Province of China [1]. It has been proven to possess multiple health-promoting effects, including antioxidation, anti-aging, and hypolipidemic efficacies [2,3]. As a well-known tea, Pu-erh tea is increasingly popular among consumers in Southeast Asia and has many derivative products. Ganpu tea is an emerging tea drink produced from Pu-erh tea and the pericarp of Citrus reticulate Chachi from Xinhui County (Guangdong Province, China) [4]. The manufacturing process of Ganpu tea is briefly summarized as follows: Whole fresh pericarp of C. reticulate Chachi is separated, filled with Pu-erh tea, dried together, and stored in a cool and ventilated place (Figure 1). The pericarp of C. reticulate “Chachi” from Xinhui County, called “Guangchenpi” (GCP) in Chinese, is widely used in cuisine and traditional medicine in China mainly due to its beneficial health effects as well as its special flavor [5,6]. Traditionally, both GCP and Pu-erh tea are considered to be of better quality if they are stored longer [1,7]. For instance, only GCP that has been stored for more than three years can be considered qualified [8]. The combination of Ganpu tea not only incorporates this characteristic but also blends the fruit flavor of GCP with the mellow taste of Pu-erh tea. Thanks to its health efficacies and special taste, Ganpu tea is increasingly favored by consumers and therefore its market demand has expanded rapidly in China. However, investigations concerning the chemical profile and biological activities of Ganpu tea are scarce.
Gut microbiota play a vital role in many aspects of human nutrition and health [9], including promoting the supply of nutrients, preventing pathogen colonization, and shaping and maintaining normal mucosal immunity [10]. Gut microbiota dysbiosis (generally with lower bacterial diversity) has been reproducibly observed in animal models and human studies with multiple diseases, such as obesity [11], diabetes [12], chronic gastrointestinal disease [13], etc. Certain foods and dietary patterns can influence the diversity and abundance of gut microbiota, which consequentially in turn affect host health. Recently, gut microbiota has emerged as a new frontier in understanding the health efficacies of functional foods and complementary medicines [14]. Both Pu-erh tea and GCP contain abundant polyphenolic compounds, which may be associated with their beneficial health properties [1,5]. After oral administration, these polyphenolic compounds will unavoidably interact with gut microbiota by modification of the microbial composition or by conversion of the phenolics to further bioactive compounds [15]. Therefore, it would be interesting to investigate whether and how Ganpu tea rich in phenolic compounds may alter gut microbiota.
This study was conducted to investigate the chemical profiles and antioxidative properties of Ganpu tea, along with its modulatory effects on gut microbiota. The chemical composition in the water extract of Ganpu tea was first profiled using a UHPLC-Q-TOF-MS/MS system. Then, oral administration experiments with the water extract of Ganpu tea were conducted in rats. The activities of antioxidant enzymes in serum were determined to evaluate the antioxidative properties of Ganpu tea. Moreover, the gut microbial community was analyzed by high throughput 16S rRNA gene sequencing.

2. Materials and Methods

2.1. Herbal Material and Chemicals

Samples of Ganpu tea and the corresponding raw materials (including Pu-erh tea and GCP) were provided by Xinhui Hele Tea Art Co. Ltd. (Jiangmen, China). The reference standards of gallic acid, caffeine, hesperidin, naringin, neohesperidin, rutin, rhoifolin, and synephrine were obtained from the National Institute for Control of Biological and Pharmaceutical Products of China (Beijing, China). Naringenin, poncirin, nobiletin, sinensetin, tangeretin, and mass spectrometry (MS) grade formic acid were purchased from Sigma-Aldrich (St. Louis, MO, USA). Hesperetin and N-methyltyramine were acquired from Sinova (Shenzhen, China). MS-grade acetonitrile was purchased from Fisher Scientific (Pittsburgh, PA, USA). Water used in the experiment was distilled and further purified with a Milli-Q system (Millipore, Milford, MA, USA). All other reagents used were of analytical grade.

2.2. Sample Preparation

The Ganpu tea sample (100 g) was cut into small pieces, and then soaked in boiled distilled water for three times (2, 1.5, and 1.5 L of each bulk, respectively, for 20, 15, and 15 min, respectively). After filtration, the whole extracts were evaporated to 500 mL by a rotary evaporator (Eyela, Tokyo, Japan) at 60 °C to obtain the Ganpu tea extract (GTE) with a concentration of 0.2 g/mL. As the whole Ganpu tea (rather than its crumb) is usually put into hot water when brewing, the average weight ratio of Pu-erh tea to GCP in Ganpu tea was experimentally determined as 8:2. To separately evaluate the effects of Pu-erh tea and GCP, a corresponding proportion of raw materials were extracted with boiled distilled water and concentrated to obtain Pu-erh tea extract (PTE) (0.16 g/mL) and GCP extract (GCPE) (0.04 g/mL). The final extracts were stored at −80 °C until further utilization.
The mixed solution of reference standards used in identification was prepared with methanol at the concentration of 10 μg /mL for each compound. The extracted solutions were filtered through a 0.22-μm microporous filter before UHPLC-Q-TOF-MS/MS analysis.

2.3. UHPLC-Q-TOF-MS/MS Analysis

Analysis of the Ganpu tea sample was performed using UHPLC-Q-TOF-MS/MS, ultra-fast liquid chromatography (Shimadzu Corp., Kyoto, Japan) coupled with quadrupole/time-of-flight mass spectrometry (Triple TOF 5600 plus, AB SCIEX, Foster City, CA, USA). Gradient chromatographic separation was performed on a Kinetex C18 column (2.6 μM, 150 mm × 3.0 mm) and maintained at 40 °C. The mobile phase consisted of acetonitrile (A) and water containing 0.1% aqueous formic acid (v/v) (B). The elution was carried out by the following program: 10–30% A (0–5 min), 30–80% A (5–27 min), 80–100% A (27–28 min), and 100% A (28–33 min) with the flow rate kept at 0.3 mL/min. The injection volume was 10 μL.
MS/MS identification was conducted using an electrospray ionization (ESI) source with the following parameters. The ion spray voltage was 5500 V in positive ion mode while −4500 V in negative ion mode. The mass range was from m/z 100 to 1500. The ion source gas 1 and gas 2 were both 55 psi, and the curtain gas was set as 35 psi. The ion source temperature was maintained at 550 °C. The declustering potential was 80 V. The collision energy and its spread was set as 35 and 25 eV, respectively. Nitrogen was used as the nebulizer and auxiliary gas. Data acquisition was carried out using Analyst® TF 1.6 software (AB Sciex, Foster City, CA, USA) in the information-dependent acquisition mode.

2.4. Animals and Experimental Design

Male Sprague-Dawley rats (weighing 180–220 g) were purchased from Guangdong Medical Experimental Animal Center and raised in the specific pathogen-free (SPF) condition. All experimental processes were approved by the Animal Ethics Committee of the School of Life Sciences in Sun Yat-sen University, and conducted according to the National Institutes of Health guide for the care and use of laboratory animals (NIH Publications No. 8023, revised 1978). Environmental conditions in the SPF houses was kept at 20 to 23 °C, 50% to 65% relative humidity, and 12-h dark/light cycle. Rats were fed for one week to adapt to the new environment before the experiments.
In total, 40 rats were randomly assigned into four groups with 10 rats in each group: Control group, GTE group (0.2 g/mL, 15 mL/kg/d), PTE group (0.16 g/mL, 15 mL/kg/d), and GCPE group (0.04 g/mL, 15 mL/kg/d). Rats were administrated a corresponding extract by gavage twice daily for 28 consecutive days. The control group received the same volume of distilled water. After the last administration, the animals were fasted for 12 h with water available ad libitum. On the next day, the rats were anesthetized with 10% chloral hydrate (3 mL/kg) by intraperitoneal injection. Blood samples were collected from the abdominal artery and then centrifuged to obtain serum samples. Feces samples were collected from the rectum of each rat, transferred into sterile conical tubes, and immediately frozen in liquid nitrogen. Obtained samples were stored at −80 °C until further analysis.

2.5. Assay of Antioxidant Enzyme Activity in Serum

Activities of serum antioxidant enzymes, including superoxide dismutase (SOD), malondialdehyde (MDA), and glutathione peroxidase (GSH-Px), were determined in accordance with the protocols of the corresponding kits (Nanjing Jiancheng Bioengineering Institute, Nanjing, China) with a spectrophotometer.

2.6. Gut Microbiota Analysis Using 16S rRNA Gene Sequencing

Total bacterial DNA were extracted from feces samples using the Power Soil DNA Isolation Kit (MO BIO Laboratories, USA) according to the manufacturer’s instructions. The 16S rRNA gene comprising V3–V4 regions was amplified by PCR using the common primers 338F (5′-ACTCCTACGGGAGGCAGCA-3′) and 806R (5′-GGACTACHVGGGTWTCTAAT-3′) combined with adapter sequences and barcode sequences. After PCR amplification, sequencing was performed on an Illumina Hiseq 2500 platform by Biomarker Technologies Co. Ltd. (Beijing, China).
The raw paired-end reads were merged using FLASH (version 1.2) [16] and filtered with Trimmomatic (version 1.2.11) [17]. All quality filtered sequencing reads were then clustered into operational taxonomic units (OTUs) based on a 97% sequence similarity according to UCLUST [18]. The OTU abundance information was normalized for further analyses of the alpha and beta diversity. Community richness and diversity estimators of Chao1, ACE, Shannon index, and Simpson index were calculated in Quantitative Insights into Microbial Ecology (QIIME) program (version 1.8) [19]. Furthermore, beta diversity analysis was utilized to evaluate the differences of samples in species complexity, which was proceeded by the gower algorithm in principal coordinate analysis (PCoA). To identify the representative taxa among each group, the linear discriminant analysis (LDA) effect size (LEfSe) algorithm was then performed with an alpha value of 0.05 and an LDA score threshold of 3.0 [20]. All processes were performed on the BMKCloud platform (www.biocloud.net).

2.7. Statistical Analysis

Data were expressed as mean ± standard deviation (SD). The significant differences between the groups were assessed by Student’s t-test in SPSS 18.0, and p < 0.05 was considered as a significant difference.

3. Results and Discussion

3.1. Identification of Chemical Compounds in GTE by UHPLC-Q-TOF-MS/MS

The chemical compounds of GTE, as well as PTE and GCPE, were characterized using UHPLC-Q-TOF-MS/MS in both positive and negative ion modes. The basic peak chromatograms (BPCs) of GTE are shown in Figure 2. The elution time, accurate molecular weights, and MS/MS fragment ions of the identified compounds are presented in Table 1. A total of 92 compounds were identified or tentatively characterized, including 63 flavonoids, 8 catechins, 14 organic acids, 6 alkaloids, and 1 limonin.
Flavonoids are an important class of plant secondary metabolites and have been shown to possess multiple biological activities, including antioxidant, anti-inflammatory, and cardioprotective properties [21,22]. In this work, a total of 63 flavonoids—comprising 12 flavonoid-O-glycosides, 7 flavonoid-C-glycosides, 11 flavonoid aglycones, and 33 polymethoxylated flavonoids—were detected in GTE. These flavonoids were mainly derived from GCP, and the corresponding MS/MS fragmentation modes were aligned with our reported results [6].
Catechins, a class of polyphenolic compounds present in tea, are regarded as a major contributor to the beneficial effects of tea diets. A total of eight catechins (compounds 6, 12, 17, 22, 23, 28, 33, and 35) were characterized in GTE. Compound 6 and 12 both gave the quasi-molecular ions [M-H] at m/z 305 and have similar fragmentation patterns. By comparing the accurate molecular weights, MS/MS fragmentation modes, and elution time with the references [23], compound 6 and 12 were proposed as gallocatechin and epigallocatechin, respectively. Typical retro-Diels–Alder (RDA) reactions were observed in the MS/MS fragmentation of these catechins. For example, with the RDA reaction involved in the cleavage of bonds 1 and 2 in the C ring, deprotonated gallocatechin (m/z 305.0664) gave its product ions at m/z 165.0119 and 139.0398 while m/z 167.0326 and 137.0228 were considered to flow from the cleavage of bonds 1 and 3. The signals at m/z 179.0447 and 125.0236 could be explained by either the cleavage of bond 5 or the simultaneous cleavage of bonds 1 and 4. In addition, the product ions at m/z 261.0807, 219.0621, and 137.0228 were yielded by the successive loss of CO2, C2H2O, and C5H6O from deprotonated gallocatechin. Another product ion at m/z 221.0413 was generated from the successive loss of C2H2O in ring A and B. The fragmentation scheme of deprotonated gallocatechin is proposed in Figure 3.

3.2. Antioxidant Activities

Oxidative stress is important in the pathogenesis of many diseases, such as diabetes, cardiovascular diseases, and neurodegenerative diseases [24]. Plant-derived polyphenolic compounds are an important class of dietary antioxidant components that may reduce the risk of these diseases [25]. Flavonoids and catechins are primary polyphenols found in GTE, which are mainly derived from GCP [26] and Pu-erh tea [1], respectively. As shown in Figure 4, both the GTE group and GCPE group could significantly increase the activities of antioxidant enzymes SOD and GSH-PX. Specifically speaking, Ganpu tea significantly enhanced the activities of SOD and GSH-PX by 13.4% (p < 0.05) and 16.3% (p < 0.01) while GCP increased their activities by 15.1% (p < 0.01) and 20.5% (p < 0.01), respectively. Correspondingly, the PTE group only significantly increased the activity of GSH-PX by 12.4% (p < 0.05). There were no significant differences in the content of MDA among the four groups of rats. The results showed that GTE and GCPE had better antioxidant capacities than PTE, suggesting that Ganpu tea and GCP may serve as natural dietary antioxidants (especially containing flavonoids).

3.3. Effects on Fecal Bacteria Composition

After 28 days of dietary intervention, feces samples were collected for an analysis of the gut microbiota community in the rats. A total of 2,542,728 high-quality sequences of the V3–V4 region of the 16S rRNA were obtained from 40 feces samples. The average sequence number was 66,914. Based on a 97% similarity level, all of the effective reads were clustered into OTUs. At the phylum level, the most abundant bacteria were Firmicutes (42.4%), Bacteroidetes (40.0%), Proteobacteria (12.3%), Actinobacteria (2.5%), and Cyanobacteria (0.95%).
After oral administration for 28 consecutive days, there was no significant differences in bacterial richness (expressed by the ACE and Chao1 index in Figure 5), diversity (expressed by the Shannon and Simpson index in Figure 5), and overall structure (shown in Figure 6) among the four groups. These results indicated that long-term consumption of GTE, PTE, or GCPE did not significantly affect the gut microbiota in healthy rats. Nevertheless, some subtle beneficial changes in gut microbiota, which were associated with the dietary consumption, were identified with the LEfSe analysis. As the threshold on the logarithmic LDA score was set at 3, a total of 39 genera were screened in the LEfSe analysis (shown in Figure 7).
Pu-erh tea is processed by microbial fermentation of sun-dried green tea leaves. Microbes play important roles in the development of the special properties of fermented Pu-erh tea [1]. Some bacteria that are common in the fermentation process of Pu-erh tea were also found to be enriched in the gut microbiota of rats in the PTE group, including Bacillus, Brachybacterium, Paenalcaligenes, and Jeotgalicoccus. Among them, Bacillus is a safe thermoduric probiotic and the dominant bacterium during the fermentation of Pu-erh tea [27]. Bacillus could produce β-glucosidase and cellulase, which would decompose the nutrients of the tea, produce organic acids, and further promote the formation of flavor substances in Pu-erh tea. Bacillus can facilitate the digestion and utilization of nutrients in the host as well. Similarly, Brachybacterium is also a cellulose-decomposing bacterium [28]. These bacteria possess essential capacities for the fermentation of non-digestible carbohydrates (e.g., dietary fibers), which are defined as food components or ingredients that are not digestible by the host [9]. This fermentation gives rise to a mass of sugar or amino acid components, which could specifically or selectively nourish beneficial colonic micro-organisms like Bifidobacterium [29].
Moreover, Pu-erh tea stimulated the relative abundance of Alistipes and Odoribacter in the gut microbiota of rats. In several studies, a significant increase of Alistipes and Odoribacter was found to be associated with a polyphenol-rich diet [30,31]. The major metabolic product of Alistipes is succinic acid [23] while Odoribacter is a butyric acid-producing bacterium [32]. These short-chain fatty acids (SCFAs), which are metabolic by-products of bacterial metabolism, play a vital role in the maintenance of colonic integrity and metabolism [33]. The available literature indicates that SCFAs could act not only as nutrients for the colonic epithelium, and modulators of intracellular pH and cell volume, but also as regulators of proliferation, differentiation, and gene expression [34].
In the GCPE group, nine genera were upregulated, with four of them belonging to the Ruminococcaceae family. Ruminococcaceae members possess a capacity to degrade plant fibers and polysaccharides to generate glucose and SCFAs, which may promote the energy intake from fiber, inhibit opportunistic pathogens, and protect the hosts against inflammation and colonic diseases [35,36]. Some studies indicated that the abundance of Ruminococcaceae family bacteria correlates negatively with arterial stiffness and endotoxemia [37,38]. Besides, the Coprococcus 3 and Eubacterium coprostanoligenes group were enriched within the GCPE group. Coprococcus 3 is a butyrate-producing genus, which could stimulate colonic motility to maintain a healthy gut [39]. The Eubacterium coprostanoligenes group can convert cholesterol to coprostanol, which is poorly absorbed in human intestines and would be excreted, leading to a reduction in the blood cholesterol concentration [40].
With the LEfSe analysis, 16 genera were found to be enriched within the GTE group. In particular, Bifidobacterium, Lactobacillus, and Lactococcus, which are well-known probiotics, were abundant in the gut microbiota of rats within the GTE group. Lactobacillus and Bifidobacterium are engaged in many functional foods and dietary supplements, with many health-promoting properties, such as the prevention of enteropathogen colonization (barrier effects) [41], reinforcement of the immune system [42,43,44], and easing digestive concerns [45]. Lactococcus lactis is a food-grade microorganism as well, and has been widely used in the food fermentation industry. Research showed that Lactococcus lactis exhibits anti-inflammatory properties in colitis [46]. Faecalibaculum was upregulated in the GTE group as well, which could produce butyrate [47]. Meanwhile, some pathogens, like Acinetobacter and Pseudomonas, were detected in the GTE group, which have been discovered in the fermentation of Pu-erh tea [27,48]. Whether they are harmless symbionts or pathogens needs further study.
Taken together, long-term dietary intake of GTE, PTE, or GCPE exerts some subtle beneficial effects in the gut microbiota of healthy rats. In particular, Ganpu tea, the mixture of Pu-erh tea and GCP, had a better capacity to stimulate the proliferation of probiotics, including Bifidobacterium, Lactobacillus, and Lactococcus. These results reveal the potential of Ganpu tea in modulating host gut microbiota, and consequentially, improving health benefits.

4. Conclusions

In this study, the chemical profiles of Ganpu tea were first investigated with a rapid UHPLC-Q-TOF-MS/MS method. A total of 92 compounds were identified or tentatively characterized, including 63 flavonoids, 8 catechins, 14 organic acids, 6 alkaloids, and 1 limonin. Furthermore, the antioxidative and gut microbiota modulatory properties of Ganpu tea were evaluated in rats after oral administration for 28 consecutive days. Ganpu tea and GCP were found to possess better antioxidant capacities than Pu-erh tea. Moreover, Ganpu tea could enhance the abundance of probiotics (including Bifidobacterium, Lactobacillus, and Lactococcus), revealing the potential of Ganpu tea in modulating the host gut microbiota to benefit human health. The obtained results would be useful in improving the utilization and consumption of Ganpu tea in functional foods/beverages, and provide essential information for further research to investigate the underlying biochemical mechanisms of its health efficiencies.

Author Contributions

Conceptualization, W.S. and Y.Z.; methodology, Y.Z., X.Z. and T.C.; formal analysis, Y.Z. and X.Z.; writing—original draft preparation, Y.Z. and X.Z.; writing—review and editing, Y.Z. and W.S.; project administration, W.P. All authors have read and agreed to the published version of the manuscript.

Funding

This research was supported by the Fundamental Research Funds for the Central Universities (2020) and the Science and Technology Planning Project of Guangdong Province in China (2019B090905002).

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Lv, H.-P.; Zhang, Y.-J.; Lin, Z.; Liang, Y.-R. Processing and chemical constituents of Pu-erh tea: A review. Food Res. Int. 2013, 53, 608–618. [Google Scholar] [CrossRef]
  2. Duh, P.D.; Yen, G.C.; Yen, W.J.; Wang, B.S.; Chang, L.W. Effects of pu-erh tea on oxidative damage and nitric oxide scavenging. J. Agric. Food Chem. 2004, 52, 8169–8176. [Google Scholar] [CrossRef] [PubMed]
  3. Kuo, K.L.; Weng, M.S.; Chiang, C.T.; Tsai, Y.J.; Lin-Shiau, S.Y.; Lin, J.K. Comparative studies on the hypolipidemic and growth suppressive effects of oolong, black, pu-erh, and green tea leaves in rats. J. Agric. Food Chem. 2005, 53, 480–489. [Google Scholar] [CrossRef] [PubMed]
  4. Zheng, Y.; Zeng, X.; Peng, W.; Wu, Z.; Su, W. Study on the discrimination between Citri Reticulatae Pericarpium varieties based on HS-SPME-GC-MS combined with multivariate statistical analyses. Molecules 2018, 23, 1235. [Google Scholar] [CrossRef] [Green Version]
  5. Yu, X.; Sun, S.; Guo, Y.; Liu, Y.; Yang, D.; Li, G.; Lu, S. Citri Reticulatae Pericarpium (Chenpi): Botany, ethnopharmacology, phytochemistry, and pharmacology of a frequently used traditional Chinese medicine. J. Ethnopharmacol. 2018, 220, 265–282. [Google Scholar] [CrossRef] [PubMed]
  6. Zheng, Y.; Zeng, X.; Peng, W.; Wu, Z.; Su, W. Characterisation and classification of Citri Reticulatae Pericarpium varieties based on UHPLC-Q-TOF-MS/MS combined with multivariate statistical analyses. Phytochem. Anal. 2019, 30, 278–291. [Google Scholar] [CrossRef]
  7. Fu, M.; Xu, Y.; Chen, Y.; Wu, J.; Yu, Y.; Zou, B.; An, K.; Xiao, G. Evaluation of bioactive flavonoids and antioxidant activity in Pericarpium Citri Reticulatae (Citrus reticulata ‘Chachi’) during storage. Food Chem. 2017, 230, 649–656. [Google Scholar] [CrossRef]
  8. Luo, Y.; Zeng, W.; Huang, K.E.; Li, D.X.; Chen, W.; Yu, X.Q.; Ke, X.H. Discrimination of Citrus reticulata Blanco and Citrus reticulata ‘Chachi’ as well as the Citrus reticulata ‘Chachi’ within different storage years using ultra high performance liquid chromatography quadrupole/time-of-flight mass spectrometry based metabolomics approach. J. Pharm. Biomed. Anal. 2019, 171, 218–231. [Google Scholar]
  9. Valdes, A.M.; Walter, J.; Segal, E.; Spector, T.D. Role of the gut microbiota in nutrition and health. BMJ 2018, 361, k2179. [Google Scholar] [CrossRef] [Green Version]
  10. Feng, Q.; Chen, W.D.; Wang, Y.D. Gut microbiota: An integral moderator in health and disease. Front. Microbiol. 2018, 9, 151. [Google Scholar] [CrossRef]
  11. Turnbaugh, P.J.; Hamady, M.; Yatsunenko, T.; Cantarel, B.L.; Duncan, A.; Ley, R.E.; Sogin, M.L.; Jones, W.J.; Roe, B.A.; Affourtit, J.P.; et al. A core gut microbiome in obese and lean twins. Nature 2009, 457, 480–484. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  12. Lambeth, S.M.; Carson, T.; Lowe, J.; Ramaraj, T.; Leff, J.W.; Luo, L.; Bell, C.J.; Shah, V.O. Composition, diversity and abundance of gut microbiome in prediabetes and type 2 diabetes. J. Diabetes Obes. 2015, 2, 1–7. [Google Scholar] [PubMed] [Green Version]
  13. Guinane, C.M.; Cotter, P.D. Role of the gut microbiota in health and chronic gastrointestinal disease: Understanding a hidden metabolic organ. Ther. Adv. Gastroenterol. 2013, 6, 295–308. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  14. Feng, W.; Ao, H.; Peng, C.; Yan, D. Gut microbiota, a new frontier to understand traditional Chinese medicines. Pharmacol. Res. 2019, 142, 176–191. [Google Scholar] [CrossRef]
  15. Manach, C.; Scalbert, A.; Morand, C.; Remesy, C.; Jimenez, L. Polyphenols: Food sources and bioavailability. Am. J. Clin. Nutr. 2004, 79, 727–747. [Google Scholar] [CrossRef] [Green Version]
  16. Tanja, M.; Salzberg, S.L. FLASH: Fast length adjustment of short reads to improve genome assemblies. Bioinformatics 2011, 27, 2957–2963. [Google Scholar]
  17. Bolger, A.M.; Marc, L.; Bjoern, U. Trimmomatic: A flexible trimmer for Illumina sequence data. Bioinformatics 2014, 30, 2114–2120. [Google Scholar] [CrossRef] [Green Version]
  18. Edgar, R.C. Search and clustering orders of magnitude faster than BLAST. Bioinformatics 2010, 26, 2460–2461. [Google Scholar] [CrossRef] [Green Version]
  19. Caporaso, J.G.; Kuczynski, J.; Stombaugh, J.; Bittinger, K.; Bushman, F.D.; Costello, E.K.; Fierer, N.; Peña, A.G.; Goodrich, J.K.; Gordon, J.I.; et al. QIIME allows analysis of high-throughput community sequencing data. Nat. Methods 2010, 7, 335–336. [Google Scholar] [CrossRef] [Green Version]
  20. Han, T.X.; Xu, X.Y.; Zhang, M.J.; Peng, X.; Du, L.L. Global fitness profiling of fission yeast deletion strains by barcode sequencing. Genome Biol. 2010, 11, R60. [Google Scholar] [CrossRef] [Green Version]
  21. Zeng, X.; Su, W.; Bai, Y.; Chen, T.; Yan, Z.; Wang, J.; Su, M.; Zheng, Y.; Peng, W.; Yao, H. Urinary metabolite profiling of flavonoids in Chinese volunteers after consumption of orange juice by UFLC-Q-TOF-MS/MS. J. Chromatogr. B 2017, 1061–1062, 79–88. [Google Scholar] [CrossRef]
  22. Zeng, X.; Su, W.; Zheng, Y.; Liu, H.; Li, P.; Zhang, W.; Liang, Y.; Bai, Y.; Peng, W.; Yao, H. UFLC-Q-TOF-MS/MS-based screening and identification of flavonoids and derived metabolites in human urine after oral administration of Exocarpium Citri Grandis extract. Molecules 2018, 23, 895. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  23. Liu, Z.; Chen, Z.; Guo, H.; He, D.; Zhao, H.; Wang, Z.; Zhang, W.; Liao, L.; Zhang, C.; Ni, L. The modulatory effect of infusions of green tea, oolong tea, and black tea on gut microbiota in high-fat-induced obese mice. Food Funct. 2016, 7, 4869–4879. [Google Scholar] [CrossRef] [PubMed]
  24. Sharma, M.; Akhtar, N.; Sambhav, K.; Shete, G.; Bansal, A.K.; Sharma, S.S. Emerging potential of citrus flavanones as an antioxidant in diabetes and its complications. Curr. Top. Med. Chem. 2015, 15, 187–195. [Google Scholar] [CrossRef]
  25. Scalbert, A.; Manach, C.; Morand, C.; Remesy, C.; Jimenez, L. Dietary polyphenols and the prevention of diseases. Crit. Rev. Food Sci. Nutr. 2005, 45, 287–306. [Google Scholar] [CrossRef] [PubMed]
  26. Sun, Y.; Wang, J.; Gu, S.; Liu, Z.; Zhang, Y.; Zhang, X. Simultaneous determination of flavonoids in different parts of Citrus reticulata ‘Chachi’ fruit by high performance liquid chromatography-photodiode array detection. Molecules 2010, 15, 5378–5388. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  27. Zhao, M.; Xiao, W.; Ma, Y.; Sun, T.; Yuan, W.; Tang, N.; Zhang, D.; Wang, Y.; Li, Y.; Zhou, H.; et al. Structure and dynamics of the bacterial communities in fermentation of the traditional Chinese post-fermented pu-erh tea revealed by 16S rRNA gene clone library. World J. Microbiol. Biotechnol. 2013, 29, 1877–1884. [Google Scholar] [CrossRef] [PubMed]
  28. Zhang, G.; Zeng, G.; Cai, X.; Deng, S.; Luo, H.; Sun, G. Brachybacterium zhongshanense sp. nov., a cellulose-decomposing bacterium from sediment along the Qijiang River, Zhongshan City, China. Int. J. Syst. Evol. Microbiol. 2007, 57, 2519–2524. [Google Scholar] [CrossRef] [PubMed]
  29. Williams, B.A.; Grant, L.J.; Gidley, M.J.; Mikkelsen, D. Gut fermentation of dietary fibres: Physico-chemistry of plant cell walls and implications for health. Int. J. Mol. Sci. 2017, 18, 2203. [Google Scholar] [CrossRef] [Green Version]
  30. Kemperman, R.A.; Gross, G.; Mondot, S.; Possemiers, S.; Marzorati, M.; Van de Wiele, T.; Doré, J.; Vaughan, E.E. Impact of polyphenols from black tea and red wine/grape juice on a gut model microbiome. Food Res. Int. 2013, 53, 659–669. [Google Scholar] [CrossRef]
  31. Mosele, J.I.; Gosalbes, M.J.; Macia, A.; Rubio, L.; Vazquez-Castellanos, J.F.; Jimenez Hernandez, N.; Moya, A.; Latorre, A.; Motilva, M.J. Effect of daily intake of pomegranate juice on fecal microbiota and feces metabolites from healthy volunteers. Mol. Nutr. Food Res. 2015, 59, 1942–1953. [Google Scholar] [CrossRef] [PubMed]
  32. Etxeberria, U.; Hijona, E.; Aguirre, L.; Milagro, F.I.; Bujanda, L.; Rimando, A.M.; Martinez, J.A.; Portillo, M.P. Pterostilbene-induced changes in gut microbiota composition in relation to obesity. Mol. Nutr. Food Res. 2017, 61. [Google Scholar] [CrossRef] [PubMed]
  33. Koh, A.; De Vadder, F.; Kovatcheva-Datchary, P.; Backhed, F. From dietary fiber to host physiology: Short-chain fatty acids as key bacterial metabolites. Cell 2016, 165, 1332–1345. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  34. Chen, C.-C.; Walker, W.A. Probiotics and prebiotics: Role in clinical disease states. Adv. Pediatr. 2005, 52, 77–113. [Google Scholar] [CrossRef] [PubMed]
  35. Shang, Q.; Shan, X.; Cai, C.; Hao, J.; Li, G.; Yu, G. Dietary fucoidan modulates the gut microbiota in mice by increasing the abundance of Lactobacillus and Ruminococcaceae. Food Funct. 2016, 7, 3224–3232. [Google Scholar] [CrossRef]
  36. Pozuelo, M.; Panda, S.; Santiago, A.; Mendez, S.; Accarino, A.; Santos, J.; Guarner, F.; Azpiroz, F.; Manichanh, C. Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome. Sci. Rep. 2015, 5, 12693. [Google Scholar] [CrossRef] [Green Version]
  37. Menni, C.; Lin, C.H.; Cecelja, M.; Mangino, M.; Matey-Hernandez, M.L.; Keehn, L.; Mohney, R.P.; Steves, C.J.; Spector, T.D.; Kuo, C.F.; et al. Gut microbial diversity is associated with lower arterial stiffness in women. Eur. Heart J. 2018, 39, 2390–2397. [Google Scholar] [CrossRef] [Green Version]
  38. Kang, C.; Wang, B.; Kaliannan, K.; Wang, X.; Lang, H.; Hui, S.; Huang, L.; Zhang, Y.; Zhou, M.; Chen, M.; et al. Gut microbiota mediates the protective effects of dietary capsaicin against chronic low-grade inflammation and associated obesity induced by high-fat diet. mBio 2017, 8. [Google Scholar] [CrossRef] [Green Version]
  39. Mancabelli, L.; Milani, C.; Lugli, G.A.; Turroni, F.; Mangifesta, M.; Viappiani, A.; Ticinesi, A.; Nouvenne, A.; Meschi, T.; van Sinderen, D.; et al. Unveiling the gut microbiota composition and functionality associated with constipation through metagenomic analyses. Sci. Rep. 2017, 7, 9879. [Google Scholar] [CrossRef] [Green Version]
  40. Li, L.; Batt, S.M.; Wannemuehler, M.; Dispirito, A.; Beitz, D.C. Effect of feeding of a cholesterol-reducing bacterium, Eubacterium coprostanoligenes, to germ-free mice. Lab. Anim. Sci. 1998, 48, 253–255. [Google Scholar]
  41. Candela, M.; Perna, F.; Carnevali, P.; Vitali, B.; Ciati, R.; Gionchetti, P.; Rizzello, F.; Campieri, M.; Brigidi, P. Interaction of probiotic Lactobacillus and Bifidobacterium strains with human intestinal epithelial cells: Adhesion properties, competition against enteropathogens and modulation of IL-8 production. Int. J. Food Microbiol. 2008, 125, 286–292. [Google Scholar] [CrossRef] [PubMed]
  42. Resta-Lenert, S.; Barrett, K.E. Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli (EIEC). Gut 2003, 52, 988–997. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  43. Masood, M.I.; Qadir, M.I.; Shirazi, J.H.; Khan, I.U. Beneficial effects of lactic acid bacteria on human beings. Crit. Rev. Microbiol. 2011, 37, 91–98. [Google Scholar] [CrossRef] [PubMed]
  44. Llopis, M.; Antolin, M.; Carol, M.; Borruel, N.; Casellas, F.; Martinez, C.; Espin-Basany, E.; Guarner, F.; Malagelada, J.R. Lactobacillus casei downregulates commensals’ inflammatory signals in Crohn’s disease mucosa. Inflamm. Bowel Dis. 2009, 15, 275–283. [Google Scholar] [CrossRef] [PubMed]
  45. Picard, C.; Fioramonti, J.; Francois, A.; Robinson, T.; Neant, F.; Matuchansky, C. Review article: Bifidobacteria as probiotic agents—Physiological effects and clinical benefits. Aliment. Pharmacol. Ther. 2005, 22, 495–512. [Google Scholar] [CrossRef]
  46. Liu, M.; Zhang, X.; Hao, Y.; Ding, J.; Shen, J.; Xue, Z.; Qi, W.; Li, Z.; Song, Y.; Zhang, T.; et al. Protective effects of a novel probiotic strain, Lactococcus lactis ML2018, in colitis: In vivo and in vitro evidence. Food Funct. 2019, 10, 1132–1145. [Google Scholar] [CrossRef]
  47. LeBlanc, J.G.; Chain, F.; Martin, R.; Bermudez-Humaran, L.G.; Courau, S.; Langella, P. Beneficial effects on host energy metabolism of short-chain fatty acids and vitamins produced by commensal and probiotic bacteria. Microb. Cell Fact. 2017, 16, 79. [Google Scholar] [CrossRef] [Green Version]
  48. Yao, J. Isolation and molecular identification of the bacterial colonization during the pile fermentation process of Pu-erh tea. J. Anhui Agric. Sci. 2013, 41, 2667–2668. [Google Scholar]
Figure 1. Manufacturing process of Ganpu tea.
Figure 1. Manufacturing process of Ganpu tea.
Nutrients 12 00224 g001
Figure 2. The basic peak chromatograms of Ganpu tea extract (GTE) in positive (a) and negative (b) ion modes.
Figure 2. The basic peak chromatograms of Ganpu tea extract (GTE) in positive (a) and negative (b) ion modes.
Nutrients 12 00224 g002
Figure 3. Proposed fragmentation scheme of deprotonated gallocatechin.
Figure 3. Proposed fragmentation scheme of deprotonated gallocatechin.
Nutrients 12 00224 g003
Figure 4. Effects of oral administration of GTE, PTE, and GCPE on the antioxidant functions in rats (n = 10, compare with the control group * p < 0.05, ** p < 0.01). (a) Superoxide dismutase (SOD) in serum; (b) malondialdehyde (MDA) content in serum; (c) glutathione peroxidase (GSH-PX) in serum.
Figure 4. Effects of oral administration of GTE, PTE, and GCPE on the antioxidant functions in rats (n = 10, compare with the control group * p < 0.05, ** p < 0.01). (a) Superoxide dismutase (SOD) in serum; (b) malondialdehyde (MDA) content in serum; (c) glutathione peroxidase (GSH-PX) in serum.
Nutrients 12 00224 g004
Figure 5. The diversity index, including ACE (a), Chao1 (b), Shannon (c) and Simpson index (d), of gut microbiota in rats in different groups (n = 10).
Figure 5. The diversity index, including ACE (a), Chao1 (b), Shannon (c) and Simpson index (d), of gut microbiota in rats in different groups (n = 10).
Nutrients 12 00224 g005
Figure 6. PCoA plots of microbial communities were based on operational taxonomic units (OTUs) composition, each treatment group is represented by a different color (n = 10).
Figure 6. PCoA plots of microbial communities were based on operational taxonomic units (OTUs) composition, each treatment group is represented by a different color (n = 10).
Nutrients 12 00224 g006
Figure 7. Differences in the gut microbiota between groups using linear discriminant analysis effect size (LEfSe) analysis at the genus level (n = 10). For taxa, which were defined as unclassified, no rank, ncultured, or Incertae-Sedis, the name of a higher taxon level was added before its taxon abbreviation (p, phylum; c, class; o, order; f, family; g, genus; s, species).
Figure 7. Differences in the gut microbiota between groups using linear discriminant analysis effect size (LEfSe) analysis at the genus level (n = 10). For taxa, which were defined as unclassified, no rank, ncultured, or Incertae-Sedis, the name of a higher taxon level was added before its taxon abbreviation (p, phylum; c, class; o, order; f, family; g, genus; s, species).
Nutrients 12 00224 g007
Table 1. Identification of the chemical compounds of Ganpu tea by ultra-high performance liquid chromatography/quadrupole-time-of-flight tandem mass spectrometry (UHPLC-Q-TOF-MS/MS).
Table 1. Identification of the chemical compounds of Ganpu tea by ultra-high performance liquid chromatography/quadrupole-time-of-flight tandem mass spectrometry (UHPLC-Q-TOF-MS/MS).
No.IdentificationMolecular FormulaRetention Time (min)[M+H]+ (Error, ppm)[M-H] (Error, ppm)Fragment Ions in the Positive Ion Mode (m/z) bFragment Ions in the Negative Ion Mode (m/z) bSource
Organic Acids and Their Esters
1Quinic acidC7H12O62.60ND d191.0205 (1.5)ND173.0446 [M-H-H2O], 127.0388, 85.0309Puerh tea
33-Glucogallic acid/4-Glucogallic acidC13H16O103.14ND331.0673 (0.7)ND169.0114 [M-H-Glc], 125.0219 [M-H-Glc-CO2]Puerh tea
4TheogallinC14H16O103.51345.0817 (−0.3)343.0673 (0.8)153.0184 [M+H-C7H12O6]+191.0545 [M-H-C7H4O4], 169.0113 [M-H-C7H10O5]Puerh tea
5Gallic acid aC7H6O53.76171.0286 (−1.1)169.0152 (3.4)153.0175 [M+H-H2O]+, 135.0063 [M+H-2H2O]+, 125.0230 [M+H-H2O-CO]+, 107.0135 [M+H-2H2O-CO]+, 81.0356125.0239 [M-H-CO2]Puerh tea
73-Caffeoylquinic acidC16H18O95.00355.1022 (3.6)353.0876 (0.8)163.0385 [M+H-C7H12O6]+, 135.0430 [M+H-C7H12O6-CO]+,191.0549 [M-H-C9H7O3], 179.0338 [M-H-C7H10O5], 135.0441 [M-H-C7H10O5-CO2]Puerh tea
9Vanillic acid cC8H8O45.29ND167.0357 (3.7)ND152.0104 [M-H-CH3],
108.0242 [M-H-C2H5]
GCP
14Caffeoyl-glucoseC15H18O95.75ND341.0881 (0.9)ND179.0339 [M-H-Glc], 161.0568 [M-H-Glc-H2O], 135.0435 [M-H-Glc-CO2]GCP, Puerh tea
153-p-Coumaroylquinic acidC16H18O85.83339.1074 (−1)337.0932 (1)147.0437 [M+H-C7H10O5-H2O]+, 119.0495 [M+H-C9H8O2-CO2-CO]+, 91.0564 [M+H-C7H10O5-HCOOH-CO]+191.0544 [M-H-C9H6O2], 163.0384 [M-H-C7H10O5], 119.0511 [M-H-C7H10O5-CO2],Puerh tea
164-Caffeoylquinic acidC16H18O95.94355.1021 (0)353.0874 (0.8)163.0387 [M+H-C7H12O6]+, 145.0277, 135.0425 [M+H-C7H12O6-CO]+,191.0547 [M-H-C9H6O3], 179.0348 [M-H-C7H10O5], 173.0442 [M-H-C9H8O4], 135.0456 [M-H- C7H10O5-CO2], 93.0364Puerh tea
245-p-Coumaroylquinic acidC16H18O86.80339.1071 (−0.6)337.0937 (2.5)147.0444 [M+H-C7H10O5-H2O]+, 119.0500 [M+H-C9H8O2-CO2-CO]+, 91.0555 [M+H-C7H10O5-HCOOH-CO]+173.0444 [M-H-C9H6O2-H2O] 163.0384 [M-H-C7H10O5], 119.0498 [M-H-C7H10O5-CO2],Puerh tea
25Caffeic acid cC9H8O46.85ND179.0362 (4.5)ND135.0443 [M-H-CO2]GCP, Puerh tea
264-p-Coumaroylquinic acidC16H18O86.93339.1074 (0.1)337.0936 (2.5)147.0447 [M+H-C7H10O5-H2O]+, 119.0497 [M+H-C9H8O2-CO2-CO]+, 91.0558 [M+H-C7H10O5-HCOOH-CO]+191.0548 [M-H-C9H6O2], 173.0446 [M-H-C9H6O2-H2O] 163.0366 [M-H-C7H10O5],
119.0504 [M-H-C7H10O5-CO2],
Puerh tea
38p-Coumaric acidC9H8O38.23ND163.0411 (2.2)ND119.0503 [M-H-CO2]Puerh tea
46Ferulic acid a,cC10H10O48.69ND193.0508 (0.7)ND178.0273 [M-H-CH3], 134.0360 [M-H-CH3-CO2],GCP
Flavan-3-ols
6GallocatechinC15H14O74.59307.081 (−0.6)305.0664 (2.1)195.0637 [M+H-CO-2C2H2O]+, 177.0532 [M+H-CO-2C2H2O-H2O]+, 139.0388 [M+H-C8H8O4]+261.0807 [M-H-CO2], 221.0413 [M-H-2C2H2O], 219.0621 [M-H-CO2-CH2O], 179.0447 [M-H-C6H6O3], 167.0326 [M-H-C7H6O3], 165.0199 [M-H-C7H8O3], 139.0398 [M-H-C8H6O4], 137.0228 [M-H- CO2-CH2O-C5H6O], 125.0236 [M-H-C9H8O4]Puerh tea
12EpigallocatechinC15H14O75.37307.0815 (0.9)305.0678 (1.5)195.1763 [M+H-CO-2C2H2O]+, 177.0544 [M+H-CO-2C2H2O-H2O]+, 139.0387 [M+H-C8H8O4]+261.0784 [M-H-CO2], 221.0439 [M-H-2C2H2O], 219.0667 [M-H-CO2-CH2O], 179.0350 [M-H-C6H6O3], 167.0242 [M-H-C7H6O3], 165.0178 [M-H-C7H8O3], 137.0234 [M-H- CO2-CH2O-C5H6O], 125.0245 [M-H-C9H8O4]Puerh tea
17CatechinC15H14O65.99291.0865 (0.6)289.0727 (2.5)207.0652 [M+H-C4H4O2]+, 179.0679 [M+H-C4H4O2-CO]+ 139.0396 [M+H-C8H8O3]+, 123.0451 [M+H-C8H8O4]+245.0818 [M-H-CO2], 205.0504 [M-H-2C2H2O], 203.0703 [M-H-CO2-C2H2O], 137.0244 [M-H-C8H8O3]Puerh tea
22EpicatechinC15H14O66.61291.0866 (0.9)289.0727 (3.4)207.0649 [M+H-C4H4O2]+, 147.0441 [M+H-C4H4O2-C2H2O-H2O]+, 139.0397 [M+H-C8H8O3]+, 123.0452 [M+H-C8H8O4]+245.0839 [M-H-CO2], 205.0505 [M-H-2C2H2O], 203.0714 [M-H-CO2-C2H2O], 161.0595 [M-H-CO2-2C2H2O], 151.0397 [M-H-C7H6O3]Puerh tea
23Epigallocatechin-3-O-gallateC22H18O116.76459.0918 (0.2)457.0787 (2.2)289.0365 [M+H-C7H6O5]+, 139.0388305.0658 [M-H-C7H4O4], 169.0123 [C7H5O5], 125.0237 [M-H-C7H4O4-C9H8O4]Puerh tea
28Gallocatechin-3-O-gallateC22H18O117.00459.0920 (0)457.0777 (1.6)289.2269[M+H-C7H6O5]+, 139.1220305.0636 [M-H-C7H4O4], 169.0137 [C7H5O5], 125.0244 [M-H-C7H4O4-C9H8O4]Puerh tea
33Epicatechin-3-O-gallateC22H18O107.86443.097 (−0.2)441.0830 (1.2)291.0484 [M+H-C7H4O4]+, 191.0347, 123.0459289.0711 [M-H-C7H4O4], 169.0131 [C7H5O5], 125.0243 [M-H-C7H4O4-C9H8O3]Puerh tea
35Catechin-3-O-gallate C22H18O108.01443.0972 (0.3)441.0824 (0.7)291.0884 [M+H-C7H4O4]+, 273.0787, 139.0393, 123.0455289.0710 [M-H-C7H4O4], 245.0819 [M-H-C7H4O4-CO2], 169.0129 [C7H5O5], 125.0244 [M-H-C7H4O4-C9H8O3]Puerh tea
Alkaloids
2Synephrine a,c C9H13NO22.72168.1014 (−4.7)ND150.0913 [M+H-H2O]+, 135.0681 [M+H-H2O-CH3]+, 107.0500 [M+H-NDGCP
H2O-CH3-CO]+, 91.0561, 77.0409, 65.0417
8Theobromine/TheophyllineC7H8N4O25.21181.0721 (0.4)179.0585 (5.7)124.0500 [M+H-C2H3NO] +,96.0567 [M+H-C2H3NO-CO]+164.0332 [M-H-CH3], 122.0354 [M-H-C2H3NO]Puerh tea
118-OxocaffeineC8H10N4O35.36211.0824 (−0.9)209.0689 (2.9)196.0589 [M+H-CH3]+, 154.0581 [M+H-C2H3NO]+,194.0432 [M-H-CH3], 137.0218 [M-H-C2H3NO-CH3]Puerh tea
19Caffeine aC8H10N4O26.32195.0877 (0.2)ND138.0658 [M+H-C2H3NO]+, 123.0425 [M+H-C2H3NO-CH3]+, 110.0714 [M+H-C2H3NO-CO]+NDPuerh tea
53Citrusin IIIC36H53N7O911.84728.3982 (0.6)726.3872 (4.4)700.4052 [M+H-CO]+, 587.3161, 474.2319696.3815, 590.3348GCP
60Citrusin IC34H53N7O913.74704.3975 (−0.4)ND686.3833 [M+H-H2O]+NDGCP
Limonoids
75Limonin cC26H30O816.65471.2013 (0)ND425.1982 [M+H-CH2O2]+, 161.0631NDGCP
Flavonoids
10AmpelopsinC15H12O85.33321.0605 (−0.1)319.046 (0.3)183.0294 [M+H-C7H6O3]+, 139.0374 [M+H-C8H6O4]+137.0239 [M-H-C8H6O4]Puerh tea
13Luteolin-6,8-di-C-glucoside cC27H30O165.73611.1599 (−1)609.1477 (2.6)593.1499 [M+H-H2O]+, 575.1404 [M+H-2H2O]+, 557.1410 [M+H−3H2O]+, 473.1021 [M+H-C4H8O4-H2O]+, 353.0650 [M+H-2C4H8O4-H2O]+489.1057 [M-H-C4H8O4], 399.0745 [M-H-C4H8O4-C3H6O3], 369.0630 [M-H-2C4H8O4]GCP
18Vicenin-2 cC27H30O156.21595.1659 (0.2)593.1531 (3.3)577.1542 [M+H-H2O]+, 559.1450 [M+H-2H2O]+ 541.1356 [[M+H-3H2O]+503.1220 [M-H-C3H6O3], 473.1112 [M-H-C4H8O4], 383.0790 [M-H-C4H8O4-C3H6O3], 353.0681 [M-H-2C4H8O4]GCP
20Chrysoeriol-6,8-di-C-glucosideC28H32O166.41625.1762 (−0.3)623.1641 (3.8)607.1664 [M+H-H2O]+, 589.1550 [M+H-2H2O]+, 571.1434 [M+H-3H2O]+, 487.1228 [M+H-C4H8O4-H2O]+, 367.0839 [M+H-2C4H8O4-H2O]+503.1236 [M-H-C4H8O4], 413.0898 [M-H-C4H8O4-C3H6O3], 383.0794 [M-H-2C4H8O4]GCP
21Narirutin cC27H32O146.43581.1855 (−1.8)579.1376 (−1.1)273.0742 [M+H-Glc-Rha]+,NDGCP
27Isoorientin cC21H20O116.95449.1079 (0.2)447.0937 (1)431.0971 [M+H-H2O]+, 413.0877 [M+H-2H2O]+, 395.0755 [M+H-3H2O]+, 329.0657 [M+H-C4H8O4]+, 299.0556 [M+H-C8H6O3]+357.0623 [M-H-C3H6O3], 327.0505 [M-H-C4H8O4]GCP
29Orientin cC21H20O117.18449.1075 (−0.7)447.0938 (2.1)431.0972 [M+H-H2O]+, 413.0860 [M+H-2H2O]+, 395.0802 [M+H-3H2O]+, 329.0644 [M+H-C4H8O4]+, 299.0561 [M+H-C8H6O3]+357.0623 [M-H-C3H6O3], 327.0505 [M-H-C4H8O4]GCP
30Rutin a,cC27H30O167.54611.1607 (0)609.1479 (2.9)465.1023 [M+H-Rha]+, 303.0498 [M+H-Rha-Glc]+301.0352 [M-H-Rha-Glc]GCP, Puerh tea
31Lonicerin cC27H30O157.60595.1656 (−0.3)593.1534 (3)449.1063 [M+H-Rha]+, 287.0548 [M+H-Glc-Rha]+285.0413 [M-H-Glc-Rha]GCP, Puerh tea
32Apigenin-8-C-glucosideC21H20O107.74433.1128 (−0.2)431.0992 (1.8)415.1031 [M+H-H2O]+, 397.0910 [M+H-2H2O]+, 379.0809 [M+H-3H2O]+, 313.0705 [M+H-C4H8O4]+, 283.0601 [M+H-C8H6O3]+341.0674 [M-H-C3H6O3], 311.0567 [M-H-C4H8O4], 283.0617 [M-H-C4H8O4-CO]GCP
34Quercetin-3-O-glucosideC21H20O127.95465.1031 (0.7)463.0887 (1)303.0497 [M+H-Glc]+301.0356 [M-H-Glc], 271.0249, 151.0024 [M-H-Glc-C8H6O3]Puerh tea
36Diosmetin-6-C-glucosideC22H22O118.08463.1237 (−0.2)461.1093 (0.8)445.1231 [M+H-H2O]+, 427.1036 [M+H-2H2O]+, 409.0924 [M+H-3H2O]+, 343.0801 [M+H-C4H8O4]+, 313.0700 [M+H-C8H6O3]+371.0829 [M-H-C3H6O3], 341.0686 [M-H-C4H8O4], 298.0489 [M-H-C4H8O4-CO-CH3]GCP
37Kaempferol-3-O-rutinosideC27H30O158.15595.1652 (−0.1)593.1529 (2.9)449.1063 [M+H-Rha]+, 287.0548 [M+H-Rha-Glc]+285.0406 [M-H-Glc-Rha]Puerh tea
39Naringin a,cC27H32O148.25581.1868 (0.6)597.1743 (4.1)419.1312 [M+H-Glc]+, 273.0762 [M+H-Rha-Glc]+, 153.0179 [M+H-Rha-Glc-C8H8O]+271.0615 [M-H-Glc-Rha], 151.0027 [M-H-Rha-Glc-C8H8O]GCP
40Rhoifolin a,cC27H30O148.30579.1713 (0.8)577.158 (2.9)433.1121 [M+H-Rha]+, 271.0599 [M+H-Rha-Glc]+269.0455 [M-H-Rha-Glc]GCP
41Diosmin cC28H32O158.47609.1868 (−0.4)607.1687 (3.4) 299.0566 [M-H-Glc-Rha], 284.0333 [M-H-Glc-Rha-CH3]GCP
42Kaempferol-3-O-glucosideC21H20O118.59449.108 (0.4)447.0944 (1)287.0561 [M+H-Glc]+284.0329 [M-H-Glc], 255.0300 [M-H-Glc-CHO], 227.0344 [M-H-Glc-CHO-CO],Puerh tea
43NeodiosminC28H32O158.60609.1811 (−0.4)607.1684 (2.6)463.1253 [M+H-Rha]+, 301.0717 [M+H-Rha-Glc]+, 286.0465 [M+H-Rha-Glc-CH3]+299.0569 [M-H-Glc-Rha], 284.0325 [M-H-Glc-Rha-CH3]GCP
44Hesperidin a,cC28H34O158.64611.1968 (−0.3)609.1849 (3.7)449.1425 [M+H-Glc]+, 303.0864 [M+H-Rha-Glc]+, 153.0181 [M+H-Rha-Glc-C9H10O2]+301.0729 [M-H-Rha-Glc], 286.0496 [M-H-Rha-Glc-CH3]GCP
45Homoeriodictyol cC16H14O68.68303.0863 (0.1)301.0722 (0.6)153.0177 [M+H-C9H10O2]+, 117.0337 [M+H-C9H10O2-2H2O]+286.0511 [M-H-CH3], 151.0032 [M-H-C9H10O2]GCP
475,3′-Dihydroxy-7,4′-dimethoxyflavone cC17H14O69.54315.0856 (−2)ND300.0617 [M+H-CH3]+, 285.0427 [M+H-2CH3]+,NDGCP
48MyricetinC15H10O89.57319.0447 (−0.4)317.0312 (2.3)273.0387 [M+H-H2O-CO]+, 245.0457 [M+H-H2O-2CO]+, 153.0185 [M+H-C8H6O4]+271.0213 [M-H-H2O-CO], 178.9975 [M-H-C7H6O3], 151.0024 [M-H-C8H6O4]Puerh tea
49Poncirin aC28H34O1410.63595.2021 (0)593.1903 (3.8)449.1415 [M+H-Rha]+, 287.0914 [M+H-Glc-Rha]+, 153.0170 [M+H-Glc-Rha-C9H10O]+285.0768 [M-H-Glc-Rha]GCP
50Isosakuranetin cC16H14O510.69287.0913 (−0.5)285.0775 (2.8)153.0173 [M+H-C9H10O]+, 133.0633 [M+H-C7H4O4]+243.0632 [M-H-C2H3O],GCP
51LuteolinC15H10O611.40287.0549 (−0.4)285.0409 (1.1)153.0203 [M+H-C8H6O2]+133.0290 [M-H-C7H4O4]Puerh tea
52Quercetin cC15H10O711.51303.0501 (0.4)301.0365 (3.8)285.0372 [M+H-H2O]+, 257.0441 [M+H-H2O-CO]+, 229.0498 [M+H-H2O-2CO]+, 153.0177 [M+H-C8H6O3]+178.9976 [M-H-C7H6O2], 151.0027 [M-H-C8H6O3]Puerh tea
54Monohydroxy-trimethoxyflavoneC18H16O612.25329.1019 (−0.1)ND314.0820 [M+H-CH3]+, 299.0540 [M+H-2CH3]+, 271,0580 [M+H-2CH3-CO]+, 181.0096, 153.0138 NDGCP
557-Hydroxy-3,5,6,8-tetramethoxyflavoneC19H18O712.69359.113 (1.3)ND344.0912 [M+H-CH3]+, 329.0663 [M+H-2CH3]+NDGCP
56Naringenin a,cC15H12O513.16273.0758 (0.1)271.0626 (2.5)153.0185 [M+H-C8H8O]+, 147.0442, 119.0500151.0032 [M-H-C8H8O], 119.0505 [M-H-C7H4O4], 107.0143 [M-H-C8H8O-CO2]GCP
57Apigenin a, cC15H10O513.30271.0601 (0.1)269.0466 (3.9)153.0175 [M+H-C8H6O]+151.003 [M-H-C8H6O]+Puerh tea
587-Hydroxy-5,6,8,4′-tetramethoxyflavone cC19H18O713.65359.1125 (−0.1)ND344.0851 [M+H-CH3]+, 329.0633 [M+H-2CH3]+, 326.0779 [M+H-CH3-H2O]+, 298.0814 [M+H-CH3-CO-H2O]+,NDGCP
59Kaempferol a,cC15H10O613.67287.055 (0.1)285.0413 (4.5)153.0170 [M+H-C8H6O2]+ Puerh tea
61Hesperetin a,cC16H14O613.76303.0865 (0.7)301.0724 (3.4)177.0546, 153.0177 [M+H-C9H10O2] +286.0484 [M-H-CH3], 151.0022 [M-H-C9H10O2]GCP
62Chrysoeriol cC16H12O613.76301.0709 (0.9)299.0571 (3.2)286.0466 [M+H-CH3]+, 258.0526 [M+H-CH3-CO]+, 229.0485 [M+H-CO2-CO]+, 153.0152 [M+H-C9H8O2]+284.0328 [M-H-CH3], 256.0393 [M-H-CH3-CO], 227.0352 [M-H-CO2-CO], 151.0010 [M-H-C9H8O2]GCP
635-Hydroxy-3,6,7,8-tetramethoxyflavoneC19H18O714.12359.1126 (0.3)ND344.0904 [M+H-CH3]+, 329.0614 [M+H-2CH3]+ 298.0815 [M+H-CH3-CO-H2O]+NDGCP
645,6,7,3′,4′-PentamethoxyflavanoneC20H22O714.36375.1441 (0.8)ND211.0594 [M+H-C10H10O2]+, 196.0361 [M+H-C10H10O2-CH3]+, 150.0311 [M+H-C10H10O2-CO-CH3-H2O]+NDGCP
657-Hydroxy-5,6,8,3′,4′-pentamethoxyflavoneC20H20O814.52389.1233 (0.4)ND374.0990 [M+H-CH3]+, 359.0759 [M+H-2CH3]+, 341.0635 [M+H-2CH3-H2O]+, 197.0073 [M+H-C10H10O2-2CH3]+NDGCP
663′-Hydroxy-5,6,7,8,4′-pentamethoxyflavone/4′-Hydroxy-5,6,7, 8,3′-pentamethoxyflavoneC20H20O814.53389.1233 (0.4)ND374.0990 [M+H-CH3]+, 359.0759 [M+H-2CH3]+, 344.0635 [M+H-3CH3]+NDGCP
676-Hydroxy-5,7,8,4′-tetramethoxyflavoneC19H18O714.80359.1124 (−0.3)ND344.0866 [M+H-CH3]+, 329.0637 [M+H-2CH3]+, 314.0393 [M+H-3CH3]+, 183.0314NDGCP
68Isosinensetin c (3′,4′,5,7,8-pentamethoxyflavone)C20H20O715.16373.1285 (0.9)ND358.1048 [M+H-CH3]+, 343.0811 [M+H-2CH3]+, 315.0865 [M+H-2CH3-CO]+NDGCP
69Monohydroxy-hexamethoxyflavoneC21H22O915.35419.1335 (−0.4)ND404.1055 [M+H-CH3]+, 389.0878 [M+H-2CH3]+NDGCP
70Monohydroxy-pentamethoxyflavanoneC20H22O815.49391.1385 (−0.6)ND241.0709 [M+H-C9H10O2]+, 226.0452 [M+H-C9H10O2-CH3]+, 211.0249 [M+H-C9H10O2-2CH3]+, 183.0300 [M+H-C9H10O2-2CH3-CO]+NDGCP
715-Hydroxy-6,7,8,4′-tetramethoxyflavoneC19H18O715.51359.1133 (2.2)ND329.0656 [M+H-2CH3]+NDGCP
725-Hydroxy-7,8,3′,4′-tetramethoxyflavoneC19H18O716.21359.1129 (1)ND344.0908 [M+H-CH3]+, 329.0672 [M+H-2CH3]+, 311.0543 [M+H-2CH3-H2O]+, 197.0043 [M+H-C10H10O2]+,169.0114 [M+H-C10H10O2-CO]+NDGCP
735,7,3′,4′-TetramethoxyflavoneC19H18O616.22343.1178 (0.5)ND328.0944 [M+H-CH3]+, 327.0881 [M+H-CH4]+, 312.0610 [M+H-CH4-CH3]+, 299.0894 [M+H-CH4-CO]+, 283.0562 [M+H-2CH4-CO]+NDGCP
74Sinensetin a,cC20H20O716.60373.1287 (1.3)ND358.1072 [M+H-CH3]+, 357.0983 [M+H-CH4]+, 343.0829 [M+H-2CH3]+, 315.0868 [M+H-2CH3-CO]+NDGCP
765,6,7,4′-TetramethoxyflavoneC19H18O616.83343.1178 (0.5)ND328.0946 [M+H-CH3]+, 327.0846 [M+H-CH4]+, 313.0710 [M+H-2CH3]+, 299.0918 [M+H-CH4-CO]+, 285.0763 [M+H-2CH3-CO]+, 153.0185NDGCP
775,7,8,3′,4′-PentamethoxyflavanoneC20H22O716.95375.1438 (0)ND211.0594 [M+H-C10H10O2]+, 196.0362 [M+H-C10H10O2-CH3]+, 168.0406 [M+H-C11H10O3-CH3]+NDGCP
78Dihydroxy-trimethoxyflavoneC18H16O717.57345.0972 (1)ND330.0747 [M+H-CH3]+, 315.0490 [M+H-2CH3]+, 301.0706 [M+H-CO2]+NDGCP
795,6,7,8,3′,4′-HexamethoxyflavanoneC21H24O817.76405.1547 (0.8)ND241.0705 [M+H-C10H10O2]+, 226.0464 [M+H-C10H10O2-CH3]+, 211.0233 [M+H-C10H10O2-2CH3]+, 183.0287NDGCP
805,7,4′-TrimethoxyflavoneC18H16O518.07313.1084 (4.4)ND298.0896 [M+H-CH3]+, 270.0929 [M+H-CO-CH3]+, 269.0823 [M+H-CO2]+NDGCP
81Nobiletin a,cC21H22O818.09403.1391 (0.8)ND388.1145 [M+H-CH3]+, 373.0905 [M+H-2CH3]+, 358.0677 [M+H-3CH3]+, 327.0853 [M+H-3CH3-OCH3]+NDGCP
82Dihydroxy-tetramethoxyflavoneC19H18O818.16375.1072 (0.9)ND360.0817 [M+H-CH3]+, 345.0568 [M+H-2CH3]+, 330.0371 [M+H-3CH3]+, 327.0484 [M+H-2CH3-H2O]+, 197.0088NDGCP
835,7,8,4′-TetramethoxyflavoneC19H18O618.39343.118 (1.2)ND327.0862 [M+H-CH4]+, 313.0710 [M+H-2CH3]+, 285.0751 [M+H-2CH3-CO]+, 282.0890 [M+H-2CH3-OCH3]+, 153.0179NDGCP
84Monohydroxy-tetramethoxyflavanoneC19H20O718.88361.1284 (0.5)ND197.0425 [M+H-C10H12O2]+, 182.0205 [M+H-C10H12O2-CH3]+, 136.0151NDGCP
853,5,6,7,8,3′,4′-HeptemethoxyflavoneC22H24O919.08433.1496 (0.8)ND418.1268 [M+H-CH3]+, 403.1024 [M+H-2CH3]+, 385.0925 [M+H-2CH3-H2O]+, 345.0610 [M+H-4CH3-CO]+NDGCP
865-Hydroxy-6,7,8,3′,4′-pentamethoxyflavanoneC20H22O819.56391.139 (0.7)ND227.0535 [M+H-C10H12O2]+, 212.0306 [M+H-C10H12O2-CH3] +,149.0224NDGCP
87Monohydroxy-tetramethoxyflavoneC19H18O719.65359.1124 (−0.3)ND344.0900 [M+H-CH3]+, 326.0762 [M+H-CH3-H2O]+, 298.0828 [M+H-CH3-CO-H2O]+, 162.0676NDGCP
88Tangeretin a,cC20H20O719.88373.1286 (1.1)ND358.1049 [M+H-CH3]+, 343.0810 [M+H-2CH3]+, 328.0584 [M+H-3CH3]+, 325.0715 [M+H-2CH3-H2O]+, 315.0868 [M+H-2CH3-CO]+NDGCP
89Monohydroxy-tetramethoxyflavoneC19H18O720.50359.1125 (0)ND344.0867 [M+H-CH3]+, 343.0808 [M+H-CH4]+, 315.0845 [M+H-CO2]+, 164.0841NDGCP
905-Hydroxy-6,7,8,3′,4′-pentamethoxyflavoneC20H20O821.20389.1234 (0.9)ND374.0984 [M+H-CH3]+, 359.0756 [M+H-2CH3]+, 341.0658 [M+H-2CH3-H2O]+, 197.0088 [M+H-C10H12O2-2CH3]+NDGCP
91NatsudaidainC21H22O922.26419.1337 (0.1)ND404.1168 [M+H-CH3]+, 389.0870 [M+H-2CH3]+, 371.0800 [M+H-2CH3-H2O]+NDGCP
92Monohydroxy-tetramethoxyflavoneC19H18O723.02359.1127 (−0.3)ND344.0886 [M+H-CH3]+, 329.0654 [M+H-2CH3]+, 311.0552 [M+H-2CH3-H2O]+, 197.0069NDGCP
a Confirmation in comparison with authentic standards. b The losses are: Glc = glucose moiety, Rha = rhamnose moiety. ND = not detect. c Confirmation in comparison with mass spectral library (Natural Products HR-MS/MS Spectral Library, Version 1.0; AB Sciex, Foster City, CA, USA). d ND = not detect.

Share and Cite

MDPI and ACS Style

Zheng, Y.; Zeng, X.; Chen, T.; Peng, W.; Su, W. Chemical Profile, Antioxidative, and Gut Microbiota Modulatory Properties of Ganpu Tea: A Derivative of Pu-erh Tea. Nutrients 2020, 12, 224. https://doi.org/10.3390/nu12010224

AMA Style

Zheng Y, Zeng X, Chen T, Peng W, Su W. Chemical Profile, Antioxidative, and Gut Microbiota Modulatory Properties of Ganpu Tea: A Derivative of Pu-erh Tea. Nutrients. 2020; 12(1):224. https://doi.org/10.3390/nu12010224

Chicago/Turabian Style

Zheng, Yuying, Xuan Zeng, Tingting Chen, Wei Peng, and Weiwei Su. 2020. "Chemical Profile, Antioxidative, and Gut Microbiota Modulatory Properties of Ganpu Tea: A Derivative of Pu-erh Tea" Nutrients 12, no. 1: 224. https://doi.org/10.3390/nu12010224

APA Style

Zheng, Y., Zeng, X., Chen, T., Peng, W., & Su, W. (2020). Chemical Profile, Antioxidative, and Gut Microbiota Modulatory Properties of Ganpu Tea: A Derivative of Pu-erh Tea. Nutrients, 12(1), 224. https://doi.org/10.3390/nu12010224

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop